Diagnostic radiopharmaceuticals for localization in target tissues exhibiting a regional PH shift relative to surrounding tissues
Creators
Description
A radiopharmaceutical chemical compound comprising a radioactive isotope, other than an isotope of iodine, in chemical combination with at least one amine group. The compound has a lipophilicity sufficiently high at a pH of 7.6 to permit passage of the compound from the blood of a mammal into a target organ or tissue and sufficiently low at a pH of 6.6 to prevent rapid return of the compound from the target organ or tissue to the blood. The compound has a percent protein binding of less than ninety percent. A method for selectively depositing a radiopharmaceutical compound in at least one target tissue or organ of a mammal, which tissue or organ has a significantly different intracellular pH than the blood of the mammal, by introducing the compound of the invention into the bloodstream of the mammal
Availability note (English)
U.S. Commissioner of Patents, Washington, D.C. 20231, USA, $.50.Additional details
Publishing Information
- Imprint Pagination
- v p.
- IPC:
- Int. Cl. A61K 43/00; A61K 49/00.
- IPC
- Int. Cl. A61K 43/00; A61K 49/00.
- Patent number
- US patent document 4,474,746/A/
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 16071484
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Non-conventional Literature
- Descriptors DEI
- AMINES; BIOLOGICAL LOCALIZATION; BLOOD; DIAGNOSIS; INTAKE; MAMMALS; NUCLEAR MEDICINE; ORGANS; PH VALUE; PROTEINS; RADIOISOTOPES; RADIOPHARMACEUTICALS; TISSUES
- Descriptors DEC
- ANIMALS; BIOLOGICAL MATERIALS; BODY; BODY FLUIDS; DRUGS; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; MEDICINE; ORGANIC COMPOUNDS; RADIOACTIVE MATERIALS; VERTEBRATES
Optional Information
- Notes
- PAT-APPL-398951.